Fact CheckerSign in

NCT06415110Enrolling by invitation

A Prospective Analysis of the Efficacy of Allosync Expand and Autograft Bone Graft in Open Lumbar Spinal Fusion

Source: ClinicalTrials.gov · Last updated 22 Aug 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The purpose of this study is to assess the radiographic and clinical outcomes of spinal fusion following use of Allosync Expand and autograft bone graft.

Status (registry)
Enrolling by invitation
Study type
Observational
Enrollment
40 (estimated)
First submitted
10 May 2024
Start date
5 Jun 2024
Primary completion date
May 2026
Lead sponsor
Research Source
NCT number
NCT06415110

What you commit to

  • Study type: Observational
  • Planned participants: 40
  • From 5 Jun 2024 to the primary completion date, May 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Subject has had prior lumbar spine fusion surgery at any level.

Other illness

  • Subject has an active local or systemic infection.
  • Patient has any condition (including malignancy), that in the opinion of the Investigator, would prohibit the patient from complying with and/or completing the protocol

Other

  • Subject has greater than grade 1 spondylolisthesis of the lumbar spine.
  • Subject is pregnant or nursing or planning to become pregnant during the two years (24 months) following arthrodesis
  • Subject is a prisoner

Who the study is looking for

  • At least 22years of age at the time of consent
  • Subject must have a documented diagnosis of spondylolisthesis up to Grade I. and have confirmed back and/or radicular pain with associated spinal stenosis as documented by conditions such as:
    • Instability as defined by \>3mm translation or \>5 degree angulation
    • Osteophyte formation of facet joints or vertebral endplates
  • Subject presents with one or more of the following:
    • Radiculopathy
    • Sensory deficit
    • Motor weakness
    • Reflex changes
  • Subject requires lumbar posterolateral arthrodesis at 1-3 contiguous levels (L1-S1).
  • The number of levels decompressed must equal the number of levels fused.
  • Subject must have been unresponsive to conservative care for at least 3 months prior to fusion surgery.
  • Subject must be willing and able to sign an informed consent document.
  • Subject must be willing and able to return for all follow-up visits, agree to participate in postoperative clinical and radiographic evaluations and comply with the required study regimen.

Age in the registry: 22 years to - · Sex: All

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Michigan Orthopaedic Surgeons
Coordinator of this site? Confirm its status
SouthfieldUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.